HEART TRANSPLANTATION - ADULT (HTX) -> HTX - Coronary Artery Vasculopathy Abstracts

274 - Cardiac Allograft Vasculopathy in Heart Transplant Recipients from Hepatitis C Viremic Donors

Presentation Number
274
Speakers
Session Name
SESSION 72 - ORAL: Hepatitis C+ Donors for Heart Transplantation: Redefining High Risk
Date
Sat, Apr 25, 2020
Time
08:15 AM - 10:00 AM
Authors

Previous ePresentation
273 - Incidence of Acute Cellular Rejection in Heart Transplant Recipients from Hepatitis C Viremic Donors -- One-Year Follow-Up

Next ePresentations
276 - Thoracotomy Approach is Associated with Less Right Ventricular Failure and Shorter Length of Stay: An Intermacs Analysis of Nearly 1000 Implants via Thoracotomy
277 - Combining Ultrafast Anaesthesia and Minimal Invasive Implantation in HeartMate 3: A Pilot Study
279 - Concomitant Cardiac Procedures during Implantation of Long-Term Continuous-Flow LVADs: A European Registry for Patients with Mechanical Circulatory Support (EUROMACS) Analysis
282 - Depressive Symptoms in Lung Transplant Recipients: Trajectory and Association with Mortality
283 - The Effect of the Cystic Fibrosis Care Center on Lung Transplant Outcomes
289 - Cardiac Transplantation for Cancer Involving the Heart: Results from 35 Years of Transplants from the ISHLT Registry
290 - De Novo Malignancy after Heart Transplantation
291 - Predictors and Clinical Outcomes of Lymphoproliferative Disorders in Heart Transplant Recipients
297 - Stroke in Pediatric Ventricular Assist Device Patients-A PediMACS Registry Analysis
299 - Inflammatory Responses in Pediatric Patients with Suspected Myocarditis